TNFSF13B and Hepatic fibrosis: Based on these premises, our aim was to investigate whether a panel of circulating B-cell-related markers—namely IgG subclasses, κ- and λ-FLCs, and BAFF—could identify distinct immune profiles across hepatic fibrosis with different etiologies.